Glenmark Pharmaceuticals turns black in Q3

17 Feb 2025 Evaluate

Glenmark Pharmaceuticals has reported results for third quarter ended December 31, 2024 (Q3FY25). 

The company has reported net profit at Rs 413.80 crore for Q3FY25 as compared to net loss of Rs 20.41 crore for the same quarter in the previous year. Total income of the company increased by 46.59% at Rs 2380.47 crore for Q3FY25 as compared to Rs 1623.91 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported net profit at Rs 347.96 crore for the quarter ended December 31, 2024 as compared to net loss of Rs 351.37 crore for the same quarter in the previous year. Total income of the company increased by 33.96% at Rs 3418.68 crore for Q3FY25 as compared to Rs 2552.11 crore for the corresponding quarter previous year.


Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×